Skip to content
Recall Observatory FDA recall evidence

Drug product

Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430. UPC 368462583401. NDC 68462-583-40

D-0349-2019

November 27, 2018

Class III

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 81639
Status
Terminated
Classification
Class III
Quantity
5,016 blister packs
Official record key
drug-enforcement:D-0349-2019

Official wording

Reason: Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.

Code information: Lot: 17180918, EXP June 2020

Distribution pattern: Nationwide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.

Field note

Send feedback

We'll only use this to respond to your feedback.